Goodwin Procter LLP advised Origin.Bio on the deal.Origin.Bio announced its US$15 million Series Seed Financing Round, led by EQT Ventures with participation from existing investor BlueYard Capital,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
